SEC Filing Details
Document Details
Form
Filing Date
Feb 10, 2020
Document Date
Feb 7, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Akero Therapeutics, Inc.
Issuer
Akero Therapeutics, Inc.
Filer
Atlas Venture Opportunity Fund I, L.P.